Get started
Author

Alessia Lancianese

Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers
2025 · Margherita Rimini, Lorenzo Fornaro, et al. · Liver International · 13
PDF
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World Setting
2026 · Federica Lo Prinzi, Margherita Rimini, et al. · International Journal of Cancer · 1
PDF
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab
2026 · Margherita Rimini, Angela Lamarca, et al. · International Journal of Cancer · 1
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis
2026 · S. Camera, A. Vogel, et al. · ESMO Open · 1
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy
2026 · Linda Bartalini, Margherita Rimini, et al. · Cancers
Overall and Line-Specific Impact of Targeted Therapies in Advanced Biliary Tract Cancer After Chemoimmunotherapy Failure
2026 · Margherita Rimini, Masafumi Ikeda, et al. · Journal of Hepatology
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study
2026 · H. Vandeputte, A. Casadei-Gardini, et al. · ESMO Gastrointestinal Oncology
PDF
Preliminary report on advanced biliary cancer patients receiving multimodality treatment in the immunotherapy era: a real-world multicentre experience
2026 · Massimiliano Salati, Eleonora Borghi, et al. · Therapeutic Advances in Medical Oncology
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease
2026 · Andrea Pretta, Pina Ziranu, et al. · Clinical Colorectal Cancer
PDF
340P Preliminary report on advanced biliary cancer receiving multimodality treatment in the immunotherapy era: A real-world multicenter experience
2025 · A. Passardi, E. Borghi, et al. · Annals of Oncology
PDF
Sustained disease control with pembrolizumab-lenvatinib in a patient with heavily pre-treated recurrent endometrial carcinoma: a case report
2025 · Alessia Lancianese, Elena Maccaroni, et al. · Drugs in Context
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study.
2025 · Andrea Pretta, Mariapaola Masiello, et al. · Journal of Clinical Oncology
PDF
Works count: 12
Citation count: 16
H-index: 1
I10-index: 1
Year
Topic
Type